Search research articles
Contact Us
Filters
Showing results (541-550 of 570) with videos related to
Page
of 57
Sort By:
Journal of the American Heart Association
|
September 26, 2023
Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report
Purnima Singh, Disheet A Shah, Mariam Jouni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2018
Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models
Caitlin D Lowery, Michele Dowless, Matthew Renschler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2018
Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group
Douglas S Hawkins, Yueh-Yun Chi, James R Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2015
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration
Nathalie Gaspar, Douglas S Hawkins, Uta Dirksen, et al.
The Lancet. Haematology
|
July 23, 2022
Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group
Tamara P Miller, Kelly D Getz, Yimei Li, et al.
JCO Precision Oncology
|
October 30, 2025
Germline Cancer Predisposition Results From the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial
Sarah Scollon, Sharon E Plon, Steven Joffe, et al.
JAMA Network Open
|
March 28, 2024
Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group
Bailey A Martin-Giacalone, He Li, Michael E Scheurer, et al.
Skeletal Muscle
|
May 23, 2019
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
Narendra Bharathy, Noah E Berlow, Eric Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2023
Outcomes After Preoperative Chemoradiation With or Without Pazopanib in Non-Rhabdomyosarcoma Soft Tissue Sarcoma: A Report From Children's Oncology Group and NRG Oncology
Aaron R Weiss, Yen-Lin Chen, Thomas J Scharschmidt, et al.
Cancer Genetics
|
May 3, 2016
Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop
Pooja Hingorani, Katherine Janeway, Brian D Crompton, et al.
Page
of 57
Search research articles
Search
Showing results (541-550 of 570) with videos related to
Sort By:
Page
of 57
Journal of the American Heart Association
|
September 26, 2023
Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report
Purnima Singh, Disheet A Shah, Mariam Jouni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2018
Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models
Caitlin D Lowery, Michele Dowless, Matthew Renschler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 10, 2018
Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group
Douglas S Hawkins, Yueh-Yun Chi, James R Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2015
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration
Nathalie Gaspar, Douglas S Hawkins, Uta Dirksen, et al.
The Lancet. Haematology
|
July 23, 2022
Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group
Tamara P Miller, Kelly D Getz, Yimei Li, et al.
JCO Precision Oncology
|
October 30, 2025
Germline Cancer Predisposition Results From the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial
Sarah Scollon, Sharon E Plon, Steven Joffe, et al.
JAMA Network Open
|
March 28, 2024
Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group
Bailey A Martin-Giacalone, He Li, Michael E Scheurer, et al.
Skeletal Muscle
|
May 23, 2019
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
Narendra Bharathy, Noah E Berlow, Eric Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 31, 2023
Outcomes After Preoperative Chemoradiation With or Without Pazopanib in Non-Rhabdomyosarcoma Soft Tissue Sarcoma: A Report From Children's Oncology Group and NRG Oncology
Aaron R Weiss, Yen-Lin Chen, Thomas J Scharschmidt, et al.
Cancer Genetics
|
May 3, 2016
Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop
Pooja Hingorani, Katherine Janeway, Brian D Crompton, et al.
Page
of 57